- Home
- AQMS vs PPCB Comparison
AQMS vs PPCB Comparison
Compare AQMS & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- PPCB
- Stock Information
- Founded
- AQMS 2014
- PPCB 2007
- Country
- AQMS United States
- PPCB Australia
- Employees
- AQMS N/A
- PPCB N/A
- Industry
- AQMS Metal Fabrications
- PPCB
- Sector
- AQMS Industrials
- PPCB
- Exchange
- AQMS Nasdaq
- PPCB Nasdaq
- Market Cap
- AQMS 24.2M
- PPCB 20.4M
- IPO Year
- AQMS 2015
- PPCB N/A
- Fundamental
- Price
- AQMS $7.40
- PPCB $1.02
- Analyst Decision
- AQMS Buy
- PPCB
- Analyst Count
- AQMS 1
- PPCB 0
- Target Price
- AQMS $12.00
- PPCB N/A
- AVG Volume (30 Days)
- AQMS 4.3M
- PPCB 185.9K
- Earning Date
- AQMS 11-12-2025
- PPCB 09-30-2025
- Dividend Yield
- AQMS N/A
- PPCB N/A
- EPS Growth
- AQMS N/A
- PPCB N/A
- EPS
- AQMS N/A
- PPCB N/A
- Revenue
- AQMS N/A
- PPCB N/A
- Revenue This Year
- AQMS N/A
- PPCB N/A
- Revenue Next Year
- AQMS $550.00
- PPCB N/A
- P/E Ratio
- AQMS N/A
- PPCB N/A
- Revenue Growth
- AQMS N/A
- PPCB N/A
- 52 Week Low
- AQMS $3.37
- PPCB $0.96
- 52 Week High
- AQMS $39.40
- PPCB $145.46
- Technical
- Relative Strength Index (RSI)
- AQMS 46.54
- PPCB N/A
- Support Level
- AQMS $6.54
- PPCB N/A
- Resistance Level
- AQMS $11.48
- PPCB N/A
- Average True Range (ATR)
- AQMS 1.50
- PPCB 0.00
- MACD
- AQMS -0.60
- PPCB 0.00
- Stochastic Oscillator
- AQMS 7.01
- PPCB 0.00
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.